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To study the topology of Na+,K+-ATPase monoclonal antibodies (MAbs) specific for membrane-bound enzyme were 
produced. Using immunofluorescence staining of viable cells or smears of a pig kidney embryonic (PKE) cell line, two 
groups of MAbs were selected, namely those binding to extra- or intracellular portions of the a-subunit. The extracellular 
location of peptide loop 804841 linking the Vth and VIth intramembrane hydrophobic segments was proved using MAb 
VG,. Another MAb, IIC,, interacting with PKE cells only after membrane perforation (4% formaldehyde and 0.1% 
Tween-20) was shown to bind to the hydrophilic loop 868945. The antigenic determinants recognized by MAb IIC, 
and VG, are located in peptides 887-904 and 81&825, respectively. The C-terminus of the a-subunit molecule was posi- 
tioned on the outer side of the cytoplasmic membrane utilizing affinity-purified antibodies to the synthetic peptide cor- 
responding to fragment 999-1008. 
(Na+ + K*)-ATPase; Monoclonal antibody; Hydrophilic loop; Transmembrane arrangement 
1. INTRODUCTION 
The Na+,K+-ATPase molecule consists of 
equimolar amounts of two polypeptides: the 
catalytic a-subunit and P-subunit with still 
unknown functions. Determination of the primary 
structures of Na+,K+-ATPases from different 
sources [l-9] initiated studies on the membrane 
topography of the enzyme molecule which should 
be crucial for the understanding of the molecular 
mechanism of the enzyme action. 
Limited proteolysis of the membrane-bound en- 
zyme [lo] and theoretical calculation of the 
hydrophobicity profile of its subunits [3,1 l] al- 
lowed us to propose a model for the arrangement 
of the pig kidney Na+,K+-ATPase protomer in the 
membrane. To confirm and fine-tune this model 
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we obtained monoclonal antibodies (MAbs) to 
Na+,K+-ATPase and isolated peptides carrying an- 
tigenic determinants. In addition, antibodies to the 
synthetic peptide covering the 999-1008 region of 
the a-subunit were produced in order to confirm 
the extracellular location of the C-terminus of the 
molecule. 
2. MATERIALS AND METHODS 
Na+,K’-ATPase was isolated from pig kidney (outer 
medulla) according to the modified procedure of Jorgensen 
[12]. The homogeneous subunits were isolated as described in 
[13]. Trypsin hydrolysis of the membrane-bound enzyme was 
performed as in [lo]. Insoluble membrane-bound tryptic pep- 
tides were immobilized on thiol-glass (CPG/Thiol, Pierce, 
USA) [14] and then cleaved with cyanogen bromide in 70% for- 
mic acid. Individual peptides were purified by HPLC and se- 
quenced. 
Hybridomas producing MAbs to Na+,K+-ATPase and its 
subunits were obtained according to De Fazekas and Scheideg- 
gar [ 151 using the myeloma cell line PAI. Balb/c mice were im- 
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munized with the purified membrane-bound enzyme according 
to the procedure proposed in [16]. Hybridomas were cloned by 
the method of limited dilutions [17]. Preparative amounts of 
MAbs were obtained from the ascitic fluid of mice and purified 
by affinity chromatography on protein A-Sepharose 4B [18]. 
The isotype and subclass of MAbs were determined by double 
immunodiffusion [19]. Affinity constants of MAbs were 
calculated from ELISA data [20]. ELISA was also used for 
screening of anti-ATPase MAb-producing hybridoma clones 
and search for epitope-bearing peptides: to perform the assay 
the membrane-bound Na+,K+-ATPase or its subunits (1 r/ml) 
or water-soluble tryptic peptides (5-10 /g/ml) were introduced 
into 96-well microtiter plates. The samples dissolved in formic 
acid were introduced in 50 ~1 aliquots and air-dried. The pep- 
tides purified by HPLC before ELISA were dissolved in PBS 
after evaporation of acetonitrile. 
The specificity of MAbs was determined by immunoblotting 
after SDS-PAGE of Na+,K+-ATPase on a 4-15% 
polyacrylamide gradient gel [21]. 
For immunofluorescence analysis, the pig embryonic cell line 
(PKE) donated by the All-Union Institute of Experimental 
Veterinary was used. Viable cells were stained by the ‘sandwich’ 
technique [17] at 4°C in the presence of 20 mM sodium azide. 
To perforate plasma membranes, PKE cells were fixed before 
staining for 10 min with 4% formaldehyde and then incubated 
in 0.1% Tween-20 or Triton X-100 for 15 min. MAb IIC9 
(5 mg/ml) was immobilized on CNBr-activated Sepharose 4B 
according to the manufacturers’s instructions. The supernatant 
from the tryptic hydrolysate containing about 20 mg of the pep- 
tides was applied to a 2 ml-immunosorbent column. The bound 
peptides were eluted with 1 M acetic acid and further purified 
by HPLC [14]. 
The decapeptide corresponding to the a-subunit 999-1008 
was synthesized following the solid phase technique [22]. The 
peptide obtained (~999, 1 mg) was conjugated with keyhole 
limpet hemocyanin [23]. Rabbits were immunized by a 2-fold 
subcutaneous injection of the conjugate (500 pg) with a 2-week 
interval. Anti-peptide antibodies (~~999) were purified by af- 
finity chromatography on Sepharose 4B with the immobilized 
synthetic peptide. Immunofluorescence staining of viable PKE 
cells with anti-peptide antibodies (250pg/ml) was carried out 
according to the above described procedure. The stained cells 
were analyzed on an EPICS-5 flow cytofluorimeter 
(Coultronics, France). The proteolytic treatment of PKE cells 
was performed under conditions providing cell viability (0.3% 
trypsin, 45 min, 37°C). 
a-subunit was studied by means of MAbs to 
Na+,K+-ATPase [ 141. 
The fusion of myeloma cells with splenocytes of 
mice immunized with the membrane-bound 
Na+,K+-ATPase resulted in the large number of 
hybridoma clones. The properties of several MAbs 
are summarized in table 1. Notably only one of 
these antibodies, IIFz, interacted with the SDS- 
denatured a-subunit. 
The topological study involved not only iden- 
tification of the exposed regions of the molecule 
but also determination of their orientation relative 
to the plasma membrane. Therefore, at the initial 
stage, we tried to find out to which fragments of 
the polypeptide chains (intracellular or ex- 
tracellular) the obtained MAbs were bound. To do 
this the immunofluorecence staining of PKE cells 
was performed. MAbs capable of staining the 
viable cells were specific to extracellular ATPase 
fragments. In contrast, MAbs that stained cells 
only after perforation of the cell membrane were 
specific for cytoplasmic domains [ 17,241. Results 
of immunofluorecence staining of PKE cells are 
listed in table 1. Of 11 MAb studies, 7 were shown 
to bind to extracellular fragments of the enzyme. 
In order to localize the antigenic determinants in 
the polypeptide chains of the membrane-bound 
Na+,K+-ATPase, the enzyme was subjected to 
limited proteolysis (1% trypsin, 10 min). The 
hydrophilic portion of the catalytic cr-subunit was 
Table 1 
Characteristics of monoclonal antibodies to the a-subunit of 
Na+,K+-ATPase 
Clone Isotype and 
subclass 
Affinity Immunofluorescence 
constant staining of PKE cells 
of MAbs (IO8 M-‘) 
Viable Cells with 
3. RESULTS AND DISCUSSION 
The two-dimensional scheme for the transmem- 
brane arrangement of Na+,K+-ATPase has been 
proposed in our laboratory on the basis of the 
hydrophobicity profile of the enzyme subunits and 
data obtained from limited proteolysis of the 
native membrane-bound complex [3,11]. In order 
to verify and fine-tune this model we employed im- 
munochemical methods. Topology of the enzyme 
IIAz 
IIAs 
IIFs 
IICS 
IIF 
IEr 
IVEj 
VG2 
VG 
11D6 
IIEn 
IgG2b 1.2 
IgG2b 2 
IgG2b 5.5 
IgGl 0.8 
IgG2b 2 
IgG2b 5 
IgGl 4.8 
IgG2b 4.6 
IgG2b 1.4 
IgG2b 20 
IgG2b 10 
cells perforated 
membrane 
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virtually, completely cleaved off [lO,ll]. The 
water-soluble part of this hydrolysate included 
peptides derived from the exposed regions of the 
molecule and bearing antigenic determinants for at 
least some of the obtained MAbs. According to 
ELISA MAb IIC9 interacted the most actively with 
hydrophilic peptides. 
Immunoaffinity chromatography was chosen as 
the key technique for isolation of the immunogenic 
peptides. To do this MAb IIC9 immobilized on 
Sepharose 4B was loaded with the freshly prepared 
water-soluble part of the tryptic hydrolysate. 
Immunosorbent-bound fragments were eluted with 
1 M acetic acid. Peptide fractions binding MAb 
IIC9 in ELISA were lyophilized, salted out and 
purified further by reverse-phase HPLC (Nucleosil 
Cis). The N-terminal sequence analysis of the 
fragments allowed their assignment o the par- 
ticular regions of the u-subunit polypeptide chain. 
Of the three peptides obtained (881-886, 887-904, 
and 881-904), only two (887-904 and 881-904) 
bound MAb IIC9 during solid-phase ELISA. It is 
quite possible that the largest fragment was 
hydrolyzed during the elution from immunosor- 
bent. Since MAb IIC9 stained PKE cells only after 
perforation of the plasma membrane, when an- 
tibody penetrated the cell, the 868-945 hydrophilic 
loop connecting the VIth and VIIth intramem- 
brane segments of the a-subunit was located in 
cytoplasm (fig. 1). 
The ELISA study of the membrane-bound frac- 
tion of the tryptic hydrolysate containing in- 
ramembrane fragments of the cY-subunit and intact 
&subunit [lo] revealed MAb VG2 to be the most 
active. Since this MAb interacted with viable cells, 
its epitope was exposed outside the cell. To localize 
the VG2 determinant, the membrane-bound 
fragments from the tryptic hydrolysate were im- 
r-. 
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Fig. 1. Model for spatial organization of the a-subunit of Na+,K+-ATPase. Regions of the polypeptide chain corresponding to antigenic 
determinants recognized by MAb IIC9, VG2 and c-p999 antibodies are marked. Coordinates of transmembrane segments are given 
as in [ll]. 
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mobilized on thiol-glass support under conditions 
identical to those described for covalent binding of 
the individual &subunit [ 131. After delipidation, 
the immobilized peptides were treated with 
cyanogen bromide and the supernatant containing 
cysteine-free peptides was analyzed. According to 
ELISA the peptide carrying epitope for MAb VG2 
was released into the supernatant. Fractionation of 
the peptides from this supernatant by reverse- 
phase HPLC followed by ELISA of the obtained 
fractions yielded the homogeneous peptide that in- 
teracted with MAb VGz. The N-terminal sequence 
analysis revealed that this peptide could be as- 
signed to the 810-825 region of the polypeptide 
chain of the cr-subunit. Fig.1 shows that the 
extracellular orientation of this region fits the 
above model well. 
The position of the C-terminus of the a-subunit 
aroused violent discussions [3,4,6]. Attempts to 
isolate the C-terminal peptide from the tryptic 
hydrolysate using MAbs were unsuccessful. 
Therefore the decapeptide (p999) corresponding to 
the 999-1008 region of the a-subunit was syn- 
thesized. The choice was made on the basis of the 
secondary structure prediction [25] since the&turn 
of the polypeptide chain should be located here. 
The small peptide size implies only one epitope. 
Therefore it was reasonable to produce polyclonal 
rather than monoclonal antibodies. Antiserum was 
raised in rabbit by immunization with p999 con- 
jugated to hemocyanin. Anti-peptide antibodies 
were purified by affinity chromatography on the 
immobilized p999. 
The antibodies obtained (cy-p999) interacted in 
ELISA with the membrane-bound enzyme. Upon 
Western blotting of Na+,K+-ATPase with a-p999 
antibodies one band corresponding in mobility to 
the a-subunit was found. These data confirmed the 
specificity of the antibodies and justify the applica- 
tion of a-p999 to topological studies. Interaction 
of m-p999 with intact PKE cells was demonstrated 
by flow cytofluorimetry. Staining of cells by a- 
p999 antibodies and FITC-labeled anti-mouse IgG 
resulted in a considerable increase of fluorescence 
intensity (3-4 times) as compared to staining with 
normal rabbit immunoglobulin. Fig.2 shows the 
increase of fluorescence intensity of virtually all 
cells which proves the presence of the corre- 
sponding epitope on the surface of PKE cells. 
Trypsin treatment of PKE cells considerably de- 
N 
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Fig.2. Cytofluorimetric analysis of intact (1,2) and trypsin- 
treated (3) PKE cells using normal rabbit IgG (1) or a-p999 
antibodies (2,3). N, the number of the cells analyzed; I, 
fluorescence intensity. 
creased the efficacy of cell staining (fig.2) though 
few cells were nevertheless stained evidently due to 
incomplete proteolysis. 
So, we established the spatial orientation of the 
VIth intramembrane segment of the cu-polypeptide 
and the extracellular location of its C-terminus and 
thus confirmed our previous model of a transmem- 
brane arrangement for the Na+,K+-ATPase 
catalytic subunit. Immunochemical investigations 
of the P-subunit arrangement are now in progress. 
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